Adverse effect of heparin in thrombin-antithrombin III interaction

Area of Science:

• Biochemistry
• Hematology

Background:

• Antithrombin III is a key inhibitor of thrombin and Factor Xa.
• Heparin is a widely used anticoagulant that potentiates antithrombin III activity.

Purpose of the Study:

• To investigate the effect of heparin on antithrombin III's inhibitory capacity.
• To understand how heparin influences thrombin and Factor Xa inhibition.

Main Methods:

• Experiments using purified human antithrombin III and thrombin.
• Assays measuring antithrombin III activity in defibrinated human plasma.
• In vitro and in vivo heparinized plasma studies with varying thrombin concentrations.

Main Results:

• Heparin, at certain concentrations, reduces antithrombin III's ability to inhibit thrombin and Factor Xa.
• In plasma, heparin can lead to thrombin accumulation when antithrombin III is deficient or when thrombin generation is continuous.
• The adverse effect of heparin on antithrombin III inhibition is dose-dependent.

Conclusions:

• Heparin's interaction with antithrombin III can be complex and may reduce its efficacy under specific conditions.
• Findings suggest potential implications for heparin therapy in patients with continuous thrombin generation or antithrombin III deficiency.